Remove 2003 Remove Competition Remove Healthcare
article thumbnail

Direct to Patient Healthcare

Healthcare Success

Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.

article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. “I think the healthcare market is probably very similar.

article thumbnail

The 4 Types of Medtech Innovation  

Cesare Ferrari

In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. The purpose of this post is to help MedTech professionals to better understand the different types of innovation.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero.

article thumbnail

Identifying The Early Adopters Of Your MedTech Product

Cesare Ferrari

The definitions by Geoffrey Moore are prevalent, and people in the healthcare business frequently refer to the concepts in his book Crossing the Chasm. In search of a better solution, they began to use manual instruments and surgical drills or competitive products. References. Crossing the Chasm. Oxford, UK: Capstone Publishing.